Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neurometrix Inc (NURO)

Neurometrix Inc (NURO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neurometrix Inc 4B GILL STREET WOBURN MASSACHUSETTS MA 01801 USA

www.neurometrix.com Employees: 13 P: 781-890-9989

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.

Key Statistics

Overview:

Market Capitalization, $K 9,433
Enterprise Value, $K 8,003
Shares Outstanding, K 2,060
Float, K 1,909
% Float 92.70%
Short Volume Ratio 0.25
% of Insider Shareholders 7.30%
% of Institutional Shareholders 19.40%

Financials:

Annual Sales, $ 3,030 K
Annual Net Income, $ -7,810 K
Last Quarter Sales, $ 580 K
Last Quarter Net Income, $ -1,780 K
EBIT, $ -8,780 K
EBITDA, $ -8,550 K

Growth:

1-Year Return 3.15%
3-Year Return -81.17%
5-Year Return -71.94%
5-Year Revenue Growth -67.31%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.75 on 11/05/24
Next Earnings Date 05/21/25
Earnings Per Share ttm -3.16
EPS Growth vs. Prev Qtr -1.35%
EPS Growth vs. Prev Year 55.36%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.150 on 03/28/07
Dividend Payable Date 04/13/07
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 11/22/23

NURO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -47.05%
Return-on-Assets % -43.30%
Profit Margin % -257.76%
Debt/Equity 0.00
Price/Sales 2.96
Price/Cash Flow N/A
Price/Book 0.66
Book Value/Share 6.98
Interest Coverage -0.10
60-Month Beta 1.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar